Clinical outcomes for early-stage nasopharyngeal carcinoma with predominantly WHO II histology treated by intensity-modulated radiation therapy with or without chemotherapy in nonendemic region of China
Author:
Affiliation:
1. Department of Radiation Oncology; Xijing Hospital; Fourth Military Medical University; Xi'an China
Publisher
Wiley
Subject
Otorhinolaryngology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/hed.23386/fullpdf
Reference22 articles.
1. Failure patterns and survival in patients with nasopharyngeal carcinoma treated with intensity modulated radiation in Northwest China: a pilot study;Wang;Radiat Oncol,2012
2. Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology;Ou;Ann Oncol,2007
3. Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: impact on future clinical trials;Cheng;Int J Radiat Oncol Biol Phys,2001
4. Treatment outcome after radiotherapy alone for patients with stage I-II nasopharyngeal carcinoma;Chua;Cancer,2003
5. Treatment outcomes after radiotherapy alone for patients with early-stage nasopharyngeal carcinoma;Xiao;Int J Radiat Oncol Biol Phys,2009
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Intensity-modulated radiotherapy alone compared with intensity-modulated radiotherapy plus concurrent chemotherapy in intermediate-risk nasopharyngeal carcinoma;Strahlentherapie und Onkologie;2024-02-07
2. Concurrent chemoradiotherapy versus radiotherapy alone in older patients with stage II nasopharyngeal carcinoma after intensity-modulated radiotherapy: A propensity score-matched cohort study;Radiotherapy and Oncology;2024-02
3. T1-2N1M0 nasopharyngeal carcinoma chemotherapy or not: A retrospective study;PLOS ONE;2023-03-02
4. Development of A Nomogram for Progression-free Survival in Patients with Stage II/T3N0 Nasopharyngeal Carcinoma to Explore Different Treatment Modalities;Journal of Cancer;2023
5. MRI-identified multidimensional nodal features predict survival and concurrent chemotherapy benefit for stage II nasopharyngeal carcinoma;Radiology and Oncology;2022-12-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3